- Home
- WYHG vs DNA Comparison
WYHG vs DNA Comparison
Compare WYHG & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WYHG
- DNA
- Stock Information
- Founded
- WYHG 1915
- DNA 2008
- Country
- WYHG China
- DNA United States
- Employees
- WYHG N/A
- DNA N/A
- Industry
- WYHG
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WYHG
- DNA Health Care
- Exchange
- WYHG NYSE
- DNA Nasdaq
- Market Cap
- WYHG 403.2M
- DNA 478.8M
- IPO Year
- WYHG 2024
- DNA N/A
- Fundamental
- Price
- WYHG $7.30
- DNA $7.45
- Analyst Decision
- WYHG
- DNA Sell
- Analyst Count
- WYHG 0
- DNA 5
- Target Price
- WYHG N/A
- DNA $17.25
- AVG Volume (30 Days)
- WYHG 52.8K
- DNA 1.5M
- Earning Date
- WYHG 05-15-2025
- DNA 05-08-2025
- Dividend Yield
- WYHG N/A
- DNA N/A
- EPS Growth
- WYHG 10.09
- DNA N/A
- EPS
- WYHG 0.27
- DNA N/A
- Revenue
- WYHG $144,231,605.00
- DNA $227,043,000.00
- Revenue This Year
- WYHG N/A
- DNA N/A
- Revenue Next Year
- WYHG N/A
- DNA $16.85
- P/E Ratio
- WYHG $4.29
- DNA N/A
- Revenue Growth
- WYHG 9.73
- DNA N/A
- 52 Week Low
- WYHG $3.55
- DNA $5.00
- 52 Week High
- WYHG $11.20
- DNA $45.20
- Technical
- Relative Strength Index (RSI)
- WYHG N/A
- DNA 50.71
- Support Level
- WYHG N/A
- DNA $7.13
- Resistance Level
- WYHG N/A
- DNA $8.58
- Average True Range (ATR)
- WYHG 0.00
- DNA 0.80
- MACD
- WYHG 0.00
- DNA 0.24
- Stochastic Oscillator
- WYHG 0.00
- DNA 68.56
About WYHG WING YIP FOOD HOLDINGS GROUP LTD SPON ADS EACH REP 1 ORD
Wing Yip Food Holdings Group Ltd is a meat producer. The company is mainly engaged in offering ready to eat and packaged meat dishes. Its product offerings include supreme crispy sausage, fully thin sausage, Chinese sausage, Dongguan Erba sausage, yellow scorpion sausage, alcohol sausage, and meat chop.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.